Dr. Davies-Cutting earned his B.Sc. from Nottingham Trent University, his M.Sc. from Birbeck College, University of London, and his Ph.D. from the University of Bristol, UK. Craig previously held various roles during his tenures with both Catalent Pharma Solutions and Glaxo SmithKline where he worked supporting the successful development of pulmonary and nasal products and drug delivery technologies from concept through commercialization.